Janssen’s Stelara approved for Crohn’s disease
HORSHAM, Pa. — Janssen Biotech Inc. has received Food and Drug Administration clearance for Stelara in treating Crohn’s disease in adults. Janssen said Monday that Stelara (ustekinumab), which is also used in the treatement of psoriasis and psoriatic arthritis, represents the first biologic therapy for Crohn’s disease targeting interleukin (IL)-12 and IL-23 cytokines, which play
